Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy and cognition: International cognition and cancer task force recommendations for harmonising preclinical research
Gordon Winocur, Ian Johnston, Hélène Castel
Cancer Treatment Reviews (2018) Vol. 69, pp. 72-83
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
Marie Lange, Florence Joly, Janette Vardy, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1925-1940
Open Access | Times Cited: 484
Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group
Ashley M. Henneghan, Kathleen Van Dyk, Tara Kaufmann, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 113, Iss. 12, pp. 1625-1633
Open Access | Times Cited: 76
Chemotherapy‐induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021
Omid Amani, Mohammad Ali Mazaheri, Mona Malekzadeh, et al.
Cancer Reports (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 12
Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions
Melanie J. Sekeres, Meenakshie Bradley-Garcia, Alonso Martínez-Canabal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12697-12697
Open Access | Times Cited: 50
Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer
Gwen Schroyen, Jeroen Blommaert, Donatienne Van Weehaeghe, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4198-4198
Open Access | Times Cited: 42
Chemotherapy-induced cognitive impairments: A systematic review of the animal literature
A. Matsos, Ian N. Johnston
Neuroscience & Biobehavioral Reviews (2019) Vol. 102, pp. 382-399
Closed Access | Times Cited: 53
A narrative review of risk factors and interventions for cancer- related cognitive impairment
Lu Bai, Enyan Yu
Annals of Translational Medicine (2021) Vol. 9, Iss. 1, pp. 72-72
Open Access | Times Cited: 36
Effect of cognitive training on patients with breast cancer reporting cognitive changes: a systematic review and meta-analysis
Xue Yan, Siqi Wei, Qianqian Liu
BMJ Open (2023) Vol. 13, Iss. 1, pp. e058088-e058088
Open Access | Times Cited: 15
The chemotherapy agent doxorubicin induces CNS expression of Ascl1, a regulator of adult neurogenesis and differentiation
Christi Anne S. Ng, Morgan Pedus, Madeline F. Lee, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors
Xuan Zhou, Xueyan Zhang, Tangsheng Zhong, et al.
Journal of Advanced Nursing (2023) Vol. 80, Iss. 2, pp. 484-499
Closed Access | Times Cited: 12
The Experience of Cancer-Related Cognitive Impairment Across Common Cancers: A Qualitative Systematic Review (Preprint)
Maryam Ibrar, Harleen Kaur, Ashleigh Main, et al.
(2025)
Closed Access
Meta-analyses of executive function deficits in chemotherapy-treated rodent models
Weiye Chen, Ian N. Johnston
Neuroscience & Biobehavioral Reviews (2025), pp. 106131-106131
Open Access
The Experience of Cancer-Related Cognitive Impairment Across Common Cancers: A Qualitative Systematic Review Protocol (Preprint)
Maryam Ibrar, Harleen Kaur, Ashleigh Main, et al.
JMIR Research Protocols (2024) Vol. 13, pp. e56888-e56888
Open Access | Times Cited: 3
Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy
Andrew Speidell, Tamar Demby, Yi‐Chien Lee, et al.
Neurotoxicity Research (2018) Vol. 35, Iss. 2, pp. 291-303
Open Access | Times Cited: 30
Methodological shortcomings of preclinical research on chemotherapy-induced cognitive impairment
Victoria Aurora Ossorio Salazar, Rudi D’Hooge
Neuroscience & Biobehavioral Reviews (2023) Vol. 150, pp. 105198-105198
Closed Access | Times Cited: 8
The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients
M.L. Gregorowitsch, A. Ghedri, Danny A. Young‐Afat, et al.
Breast Cancer Research and Treatment (2019) Vol. 175, Iss. 2, pp. 429-441
Open Access | Times Cited: 23
Mitochondrial-associated impairments of temozolomide on neural stem/progenitor cells and hippocampal neurons
Naomi Lomeli, Kaijun Di, Diana C. Pearre, et al.
Mitochondrion (2020) Vol. 52, pp. 56-66
Open Access | Times Cited: 22
Cognitive complications of cancer and cancer-related treatments – Novel paradigms
Naomi Lomeli, Javier Lepe, Kalpna Gupta, et al.
Neuroscience Letters (2021) Vol. 749, pp. 135720-135720
Open Access | Times Cited: 18
Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe
Charlotte Sleurs, Ali Amidi, Lisa M. Wu, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103859-103859
Open Access | Times Cited: 13
Long-term clinically relevant rodent model of methotrexate-induced cognitive impairment
Connor Berlin, Katharine R Lange, H. Carl LeKaye, et al.
Neuro-Oncology (2020) Vol. 22, Iss. 8, pp. 1126-1137
Open Access | Times Cited: 20
A mouse model of chemotherapy-related cognitive impairments integrating the risk factors of aging and APOE4 genotype
Tamar Demby, Olga Rodriguez, Camryn W. McCarthy, et al.
Behavioural Brain Research (2020) Vol. 384, pp. 112534-112534
Open Access | Times Cited: 19
The effectiveness of anti-inflammatory agents in reducing chemotherapy-induced cognitive impairment in preclinical models – A systematic review
Olivia J. Haller, Ines Semendric, Rebecca P. George, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 148, pp. 105120-105120
Open Access | Times Cited: 5
How to assess and manage cognitive impairment induced by treatments of non-central nervous system cancer
Marie Lange, Hélène Castel, Johan Le Fel, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 602-614
Open Access | Times Cited: 15
Dissolving Microneedles: Standing Out in Melanoma Treatment
Jingting Huang, Xihao Wang, Zhengyong Li
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 45, pp. 11573-11595
Closed Access | Times Cited: 1
Exercise May Affect Metabolism in Cancer-Related Cognitive Impairment
Muhammad Shahid, Jayoung Kim
Metabolites (2020) Vol. 10, Iss. 9, pp. 377-377
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top